JUAN MEDINA: Open Payments
NPI 1265485106 · CARLINVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 51 payments from 11 companies in 2025. Trend: 2023 $1,707 · 2024 $1,616 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $251 |
| Vanda Pharmaceuticals Inc. | 8 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Corium, LLC | 6 | $117 |
| Lundbeck LLC | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: VRAYLAR, FANAPT, TRINTELLIX, CAPLYTA, Azstarys, REXULTI, INGREZZA, Sunosi.
Industry payments across IL — which companies pay providers there.
